Evidence map›Paper›PMID 40241818›Full record

ArticleSurgery open science2025

Prolonged allograft survival in liver transplantation.

Yash Kadakia, Andrew D Shubin, Malcolm MacConmara, Madhukar S Patel, Jorge A Sanchez-Vivaldi, Lauren E Matevish, Steven I Hanish, Parsia A Vagefi, Christine S Hwang

Abstract read
In one paragraph

Article in Surgery open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yash KadakiaDepartment of Surgery, University of Pennsylvania, Pennsylvania Hospital, Philadelphia, PA, USA.
Andrew D ShubinDepartment of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Malcolm MacConmaraTransMedics Inc, Andover, MA, USA.
Madhukar S PatelDepartment of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jorge A Sanchez-VivaldiPrograma Transplante Hígado Adulto Y Pedíatrico, Auxilio Mutuo, San Juan, PR, USA.
Lauren E MatevishDepartment of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Steven I HanishDivision of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Parsia A VagefiDepartment of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Christine S HwangDepartment of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Donor age has traditionally been considered a factor associated with allograft failure in liver transplantation. We sought to examine the characteristics and outcomes of all liver allografts with a cumulative age of over 80 years within the US to better understand liver senescence. Methods: Using the UNOS STARfile, allografts with a cumulative age (sum of age at transplant plus post-transplant survival) of octogenarian, 90-99 nonagenarian, and 100 years or greater (centurion) were identified from all adult transplant recipients between 1990 and 2022. Donor and recipient data as well as outcomes were analyzed. Results: There were 3437 octogenarian, 622 nonagenarian, and 29 centurion allografts. Donors from allografts with prolonged cumulative age had less diabetes, less alcohol use, and fewer infections compared to all other donors. Recipients had significantly lower MELD scores at the time of transplant and dialysis rates. Conclusions: Careful matching of older donors with lower MELD recipients results in excellent outcomes as evidenced by the presence of prolonged cumulative age livers, demonstrating the resilience of the liver to senescent events in appropriately matched recipients.

Indexed as

Donor ageLiverOutcomesTransplant

Identifiers

PMID40241818
PMCPMC12002961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.